A Novel Therapeutic Combination Sequentially Targeting Aurora B and Bcl-xL in Hepatocellular Carcinoma

被引：0
|
作者：
Hiroko Matsunaga
Shinji Tanaka
Arihiro Aihara
Kousuke Ogawa
Satoshi Matsumura
Daisuke Ban
Takanori Ochiai
Takumi Irie
Atsushi Kudo
Noriaki Nakamura
Shigeki Arii
Minoru Tanabe
机构：
[1] Tokyo Medical and Dental University,Department of Hepato
[2] Tokyo Medical and Dental University,Biliary
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
HuH7 Cell; Subcutaneous Xenograft; Bone Marrow Nucleate Cell; Inhibitor AZD1152; AZD1152 Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3079 / 3086
页数：7
相关论文
共 50 条
  • [1] A Novel Therapeutic Combination Sequentially Targeting Aurora B and Bcl-xL in Hepatocellular Carcinoma
    Matsunaga, Hiroko
    Tanaka, Shinji
    Aihara, Arihiro
    Ogawa, Kousuke
    Matsumura, Satoshi
    Ban, Daisuke
    Ochiai, Takanori
    Irie, Takumi
    Kudo, Atsushi
    Nakamura, Noriaki
    Arii, Shigeki
    Tanabe, Minoru
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (09) : 3079 - 3086
  • [2] Targeting Bcl-xL in fibrolamellar hepatocellular carcinoma
    Shebl, Bassem
    Lalazar, Gadi
    Ng, Denise
    Finkelstein, Tova
    Zheng, Guangrong
    Zhang, Peiyi
    Rosemore, Carly
    Ortiz, Michael
    Zhou, Daohong
    Simon, Sanford
    Coffino, Philip
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
    Shebl, Bassem
    Ng, Denise
    Lalazar, Gadi
    Rosemore, Carly
    Finkelstein, Tova M.
    Migler, Rachael D.
    Zheng, Guangrong
    Zhang, Peiyi
    Jiang, Caroline S.
    Qureshi, Adam
    Vaughan, Roger
    Yarchoan, Mark
    de Jong, Ype P.
    Rice, Charles M.
    Coffino, Philip
    Ortiz, Michael V.
    Zhou, Daohong
    Simon, Sanford M.
    JCI INSIGHT, 2022, 7 (17)
  • [4] THERAPEUTIC EFFECT BY TARGETING BCL-XL PROTEIN IN UROTHELIAL CARCINOMA CELLS
    Yoshimine, Shunsuke
    Kikuchi, Eiji
    Kosaka, Takeo
    Miyajima, Akira
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2014, 191 (04): : E230 - E230
  • [5] Bcl-xL overexpression in human hepatocellular carcinoma
    Watanabe, J
    Kushihata, F
    Honda, K
    Mominoki, K
    Matsuda, S
    Kobayashi, N
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (03) : 515 - 519
  • [6] Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
    Yoshimine, S.
    Kikuchi, E.
    Kosaka, T.
    Mikami, S.
    Miyajima, A.
    Okada, Y.
    Oya, M.
    BRITISH JOURNAL OF CANCER, 2013, 108 (11) : 2312 - 2320
  • [7] Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
    S Yoshimine
    E Kikuchi
    T Kosaka
    S Mikami
    A Miyajima
    Y Okada
    M Oya
    British Journal of Cancer, 2013, 108 : 2312 - 2320
  • [8] Prognostic significance of Bcl-xL in human hepatocellular carcinoma
    Watanabe, J
    Kushihata, F
    Honda, K
    Sugita, A
    Tateishi, N
    Mominoki, K
    Matsuda, S
    Kobayashi, N
    SURGERY, 2004, 135 (06) : 604 - 612
  • [9] Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma
    Clare M. Adams
    Ramkrishna Mitra
    Ashley N. Vogel
    Jinglan Liu
    Jerald Z. Gong
    Christine M. Eischen
    Leukemia, 2020, 34 : 947 - 952
  • [10] Bcl-xL as a critical apoptosis antagonist in hepatocytes and hepatocellular carcinoma
    Takehara, T
    Hayashi, N
    STEM CELL AND LIVER REGENERATION, 2004, : 57 - 64
12345